Literature DB >> 8467556

Increased expression of interferon-gamma in hyperplastic lymph nodes from HIV-infected patients.

M J Boyle1, M F Berger, M Tschuchnigg, J E Valentine, B G Kennedy, M Divjak, D A Cooper, J J Turner, R Penny, W A Sewell.   

Abstract

Polyclonal B cell activation is characteristic of HIV infection and occurs in the presence of severe CD4+ lymphocyte depletion. In contrast, CD4+ lymphocytes are the dominant T cell in the reactive lymphoid tissues of patients not infected with HIV. In this study, lymph node biopsies from eight HIV-infected patients with persistent generalized lymphadenopathy syndrome (PGL) were assessed for IL-1 beta, IL-2, IL-4, IL-6, IL-10, interferon-gamma (IFN-gamma) and tumour necrosis factor-beta (TNF-beta) gene expression using the polymerase chain reaction (PCR). The cytokine gene expression of two cases of reactive adenopathy in patients not infected with HIV was assessed for comparison. IFN-gamma was expressed much more strongly in the PGL samples than in control reactive lymphoid tissues, whereas the other cytokines were expressed to a similar extent in both types of tissues. IFN-gamma may have an important role in maintaining the adenopathy of HIV-infected patients. Expression of cytokines such as IL-2, IL-4 and IL-10 in HIV nodes may be adequate to allow the recruitment of naive B cells to the reactive process.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8467556      PMCID: PMC1554867          DOI: 10.1111/j.1365-2249.1993.tb05954.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Microbicidal activity of monocyte derived macrophages in AIDS and related disorders.

Authors:  L J Eales; O Moshtael; A J Pinching
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

2.  Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities.

Authors:  T Yokota; T Otsuka; T Mosmann; J Banchereau; T DeFrance; D Blanchard; J E De Vries; F Lee; K Arai
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus.

Authors:  S M Schnittman; H C Lane; S E Higgins; T Folks; A S Fauci
Journal:  Science       Date:  1986-09-05       Impact factor: 47.728

4.  Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines.

Authors:  L Montagnier; J Gruest; S Chamaret; C Dauguet; C Axler; D Guétard; M T Nugeyre; F Barré-Sinoussi; J C Chermann; J B Brunet
Journal:  Science       Date:  1984-07-06       Impact factor: 47.728

5.  Evolution of the functional human beta-actin gene and its multi-pseudogene family: conservation of noncoding regions and chromosomal dispersion of pseudogenes.

Authors:  S Y Ng; P Gunning; R Eddy; P Ponte; J Leavitt; T Shows; L Kedes
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

6.  Stages in LAV/HTLV-III lymphadenitis. I. Histological and immunohistological classification.

Authors:  G Pallesen; J Gerstoft; L Mathiesen
Journal:  Scand J Immunol       Date:  1987-01       Impact factor: 3.487

7.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.

Authors:  T Hirano; K Yasukawa; H Harada; T Taga; Y Watanabe; T Matsuda; S Kashiwamura; K Nakajima; K Koyama; A Iwamatsu
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

8.  cDNA cloning of IL-1 alpha and IL-1 beta from mRNA of U937 cell line.

Authors:  T Nishida; N Nishino; M Takano; K Kawai; K Bando; Y Masui; S Nakai; Y Hirai
Journal:  Biochem Biophys Res Commun       Date:  1987-02-27       Impact factor: 3.575

9.  Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity.

Authors:  O Martínez-Maza; E Crabb; R T Mitsuyasu; J L Fahey; J V Giorgi
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

10.  Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity.

Authors:  P W Gray; B B Aggarwal; C V Benton; T S Bringman; W J Henzel; J A Jarrett; D W Leung; B Moffat; P Ng; L P Svedersky
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

View more
  12 in total

1.  HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor.

Authors:  Maria A De Francesco; Manuela Baronio; Simona Fiorentini; Costantino Signorini; Carlo Bonfanti; Claudio Poiesi; Mikulas Popovic; Manuela Grassi; Emirena Garrafa; Luisa Bozzo; George K Lewis; Stefano Licenziati; Robert C Gallo; Arnaldo Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-08       Impact factor: 11.205

2.  High frequency of virus-specific B lymphocytes in germinal centers of simian-human immunodeficiency virus-infected rhesus monkeys.

Authors:  David H Margolin; Erika F Helmuth Saunders; Benjamin Bronfin; Nicole de Rosa; Michael K Axthelm; Xavier Alvarez; Norman L Letvin
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Human endothelial cells enhance human immunodeficiency virus type 1 replication in CD4+ T cells in a Nef-dependent manner in vitro and in vivo.

Authors:  Jaehyuk Choi; Jason Walker; Sergei Boichuk; Nancy Kirkiles-Smith; Nicholas Torpey; Jordan S Pober; Louis Alexander
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 4.  Expansion or depletion of T follicular helper cells during HIV infection: consequences for B cell responses.

Authors:  Olusegun O Onabajo; Joseph J Mattapallil
Journal:  Curr HIV Res       Date:  2013-12       Impact factor: 1.581

5.  Cytokine expression by high-density human lymphocytes.

Authors:  W A Sewell; M F Berger; L J Skipsey; M A Cooley; H S Warren
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

6.  Down-regulation of CXCR-4 and CCR-5 expression by interferon-gamma is associated with inhibition of chemotaxis and human immunodeficiency virus (HIV) replication but not HIV entry into human monocytes.

Authors:  D Creery; W Weiss; W T Lim; Z Aziz; J B Angel; A Kumar
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

7.  Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection.

Authors:  Brett D Shepard; Mona R Loutfy; Janet Raboud; Frank Mandy; Colin M Kovacs; Christina Diong; Michele Bergeron; Victoria Govan; Stacey A Rizza; Jonathan B Angel; Andrew D Badley
Journal:  J Acquir Immune Defic Syndr       Date:  2008-06-01       Impact factor: 3.731

Review 8.  Cell-cycle dysregulation in the immunopathogenesis of AIDS.

Authors:  M Paiardini; B Cervasi; R Dunham; B Sumpter; H Radziewicz; G Silvestri
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

9.  Differential effects of human immunodeficiency virus type 1 envelope protein gp120 on interferon production by mononuclear cells from adults and neonates.

Authors:  M P Nair; K C Chadha; I Stadler; A Sweet; S A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

10.  Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection.

Authors:  V Navikas; J Link; B Wahren; C Persson; H Link
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.